|
|
4382 Round Lake Road West
St. Paul, MN 55112-3923 USA
phone:651/639-1227
fax:651/639-1338
|
|
| Symbol |
MDWV |
| Exchange |
Nasdaq |
| Founded |
1984 |
| Employees |
27 |
|
|
| www.mdwv.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Non-invasive, blood pressure measurement and monitoring systems. |
|
| Management |
| Frank A. Katarow, President and CEO; Ramon L. Burton, CFO; Ms. Teresa Kalinowsky, VP of Fin. |
| |
|
|
|
|
|
|
|
| Keywords |
| blood pressure, monitoring, cardiology, Cardiology, cardiac, heart |
|
|
|
| Description |
|
Medwave develops, manufactures and distributes sensor-based, non-invasive blood pressure measurement and monitoring systems and related technologies. |
|
| Products / Services |
Medwave's non-invasive blood pressure monitoring products include the Primo and Vasotrac hand-held monitors. Primo is a portable wrist-based non-invasive spot blood pressure measurement system and can fit a wide variety of patients.
|
|
| Technology / Differentiation |
| Products utilize the company's proprietary algorithms and sensors, which analyze the pressure waveforms to calculate the systolic, diastolic, mean pressure readings, and pulse rate approximately every 15 heartbeats. |
|
| Market / Customers |
The company's products are designed for use in hospitals, clinics, doctor's offices and almost anywhere else blood pressure monitoring takes place. Medwave has the required technology clearances to market its technology in the United States, Europe, and Asia. Medwave's technology is installed in over 500 hospitals and clinics worldwide. The hospital market and alternative care market is estimated to be greater than $600 million annually for point of care devices.
|
|
| Strategy |
Medwave works with leading group purchasing organizations (GPOs), including Novation, Broadlane, Amerinet (including AllHealth), Mayo Foundation, Tenet Healthcare and Sisters of Charity of Leavenworth. Novation represents about 75% of U.S. etaching hospitals, allowing Medwave's products to gain traction with future decision makers.
|
|
| Funding |
| Medwave announced in February 2006 that it received over $4.4 million in capital funding that was led by H&Q Healthcare Investors and H&Q Life Sciences Investors. Medwave will use the cash to fuel growth and market its products, including the Primo system and Legato OEM Developer's kit. |
|
| Status |
| In June 2006, Medwave announced that it has submitted a 510(k) application to the FDA for its Fusion Non-Invasive Patient Monitor System with Vital Signs Options. In February 2006, Medwave received FDA 510(k) clearance to sell its Primo spot blood pressure device in U.S. point of care markets. Medwave is also working to expand distribution of Primo into numerous regions of the world. Medwave estimates the worldwide market for point-of-care blood pressure monitoring is $600 million. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members